FDA Inspection 1064675 — Aspirus - Wausau Hospital
The FDA completed an inspection of Aspirus - Wausau Hospital on Aug 31, 2018 in Wausau, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 31, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wausau, WI (United States)